NASDAQ •
Healthcare •
Biotechnology •
Quote as of 06/26/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization4.63 mln
Float10.15 mln
Earnings Date08/19/2026
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-3.33
Reliable
Relative Strength
43
/ 100
Slightly lagging
Debt / Equity
0.47
Low leverage
ROE
-107
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
CollPlant Biotechnologies is an Israeli company that grows human collagen from plants and uses it to develop medical products. Its offerings include tissue fillers, wound care treatments, tendon repair solutions, and 3D-printed breast implants, with operations spanning the US, Canada, Europe, and beyond. The company also supplies collagen-based materials to other researchers and manufacturers working in regenerative medicine, and works alongside partners such as AbbVie and Stratasys to advance its technology.
